Cargando…
Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials
BACKGROUND/AIMS: Numerous reasons have been identified for why U.S.-based principal investigators choose to not continue participating in FDA-regulated trials. However, unexplored are reasons why a substantial number of principal investigators, facing the same challenges, remain engaged in clinical...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926102/ https://www.ncbi.nlm.nih.gov/pubmed/31890985 http://dx.doi.org/10.1016/j.conctc.2019.100502 |